Pro-Inflammatory Cytokines: New Potential Therapeutic Targets for Obesity-Related Bone Disorders
Journal:
Current Drug Targets
Volume:
18
Page:
1664-1675
Author(s):
Tiantian Wang, Chengqi He* and Xijie Yu*
Nanotechnology for Alzheimer Disease
Journal:
Current Alzheimer Research
Volume:
14
Page:
1182-1189
Author(s):
Jerzy Leszek, Ghulam Md Ashraf, Wai Hei Tse, Jin Zhang, Kazimierz Gasiorowski, Marco Fidel Avila-Rodriguez, Vadim V. Tarasov, George E. Barreto, Sergey G. Klochkov, Sergey O. Bachurin and Gjumrakch Aliev*
Nano-Delivery in Pediatric Tumors: Looking Back, Moving Forward
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1328-1343
Author(s):
Marta Colletti, Virginia Di Paolo, Angela Galardi, Giuseppe Maria Milano, Angela Mastronuzzi, Franco Locatelli and Angela Di Giannatale*
Pathological and Therapeutic Aspects of Long Noncoding RNAs in Osteosarcoma
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1312-1316
Author(s):
Kaixiu Wang, Wei Jiang, Chao Cheng, Yusheng Li* and Min Tu*
Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Journal:
Current Vascular Pharmacology
Volume:
15
Page:
503-519
Author(s):
Muthu K. Shanmugam, Sudha Warrier, Alan P. Kumar*, Gautam Sethi* and Frank Arfuso
Pathobiology and Therapeutic Implications of Tumor Acidosis
Journal:
Current Medicinal Chemistry
Volume:
24
Page:
2827-2845
Author(s):
Jenny Viklund, Sofia Avnet and Angelo De Milito*
miR-126 as a Therapeutic Agent for Diabetes Mellitus
Journal:
Current Pharmaceutical Design
Volume:
23
Page:
3309-3314
Author(s):
Elham Pishavar and Javad Behravan*
15,16-dihydrotanshinone I Induces Apoptosis and Inhibits the Proliferation, Migration of Human Osteosarcoma Cell Line 143B in vitro
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1234-1242
Author(s):
Xuepeng Chen*, Qihong Li, Yan He, Hongjiang Du, Zhajun Zhan, Hong Zhao, Jiejun Shi, Qingsong Ye and Ji’an Hu*
Congenital Malformations Attributed to Prenatal Exposure to Cyclophosphamide
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1211-1227
Author(s):
Padmanabhan Rengasamy*
Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
17
Page:
1278-1291
Author(s):
Julia Alejandra Pezuk*, Maria Sol Brassesco, Priscila Maria Manzini Ramos, Carlos Alberto Scrideli and Luiz Gonzaga Tone